MGRC | MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD
0.250 (8.7%)
T-O (am): 0.225 (08:59:00)
Last updated: 16:52
MGRC Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
MGRC Historical Dividends
MGRC Financial Ratios
| EPS | -3.03 sen |
| Trailing PE (Sector Median: 22.6) | 0.0 |
| PEG | 0.0 |
| Altman Z | -1.7 |
| Beaver | -0.18 |
| Current Ratio | 5.93 |
| Debt-Equity (DE) Ratio | 0.2 |
| FCF Yield | -2.69 % |
| Revenue QoQ | -6.57 % |
| Revenue YoY | -41.46% |
| Profit QoQ | 46.77 % |
| Profit YoY | 91.86 % |
| Profit Margin (Sector Median: 5.7) | -71.94 % |
| ROE (ROIC: -95.3) | -95.3 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
MGRC Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 22.6) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 5.7) | |
| ROE (ROIC: -95.3) | |
| Altman Z |
MGRC Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.13 |
| Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | -0.49 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0.0 |
| Expected Revenue (M) | 0.0 |
| Expected Growth (%) | 0.0 |
MGRC Directors Share Purchases (Beta)
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 2370000.0 units announced on 08 Aug 2022 at ~RM0.73
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 13 Jul 2022 at ~RM0.955
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 100000.0 units announced on 12 Jul 2022 at ~RM0.945
ENCIK NOOR AZRI BIN DATO' SRI NOOR AZERAI added 120000.0 units announced on 08 Jun 2022 at ~RM0.63
DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 694000.0 units announced on 16 Jul 2021 at ~RM1.56
DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 851679.0 units announced on 24 Feb 2021 at ~RM1.19
TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 10 Feb 2021 at ~RM0.88
DATUK MUNIRAH BINTI HAJI ABDUL HAMID reduced 354070.0 units announced on 07 Jan 2021 at ~RM1.05
TAN SRI DATUK DR RAFIAH BINTI SALIM added 20000.0 units announced on 24 Dec 2020 at ~RM0.885
TAN SRI DATUK DR RAFIAH BINTI SALIM added 10000.0 units announced on 22 Dec 2020 at ~RM0.83
TAN SRI DATUK DR RAFIAH BINTI SALIM added 60000.0 units announced on 16 Dec 2020 at ~RM0.78
MGRC Summary
Market Cap: 34 M.
Market Cap Class: Shrimp
Number of Shares: 137 M.
Adjusted Float: 87.3%.
Stock highly correlated with
CJCEN (95%)
PCHEM (95%)
AMTEL (94%)
BAT (94%)
MGRC provides genome sequencing and analysis services. Our services and pipelines are designed to rapidly sequence and analyse large volumes of genetic data and extract meaningful biological information for downstream research and development. The key components of our commercial operations are our Contract Genomics Services, Sequencing Services, and Data and Access Services. Our services and applications have been used extensively in significant projects, including the mapping of the lung cancer genome, and the sequencing and assembly of the oil palm genome. To date, the company have undertaken projects for large agriculture-based companies, major medical research institutions, and government linked or funded entities in Malaysia and abroad, including United States and Australia. Currently, MGRC are the only player in Malaysia providing commercial bioinformatics analysis services for data from multiple second and third generation sequencing machines, serving public and private sector organizations in Malaysia and internationally. They have established themselves as Malaysia's leading provider of Contract Genomics Services
Sectors: Healthcare, Health Care Equipment & Services, Penny Stocks
Share Registrar: ALDPRO CORPORATE SERVICES SDN BHD
Code: 0155
Website: http://www.mgrc.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
No warrants listed
MGRC Top Shareholdings
Updated on 30-Sep-2022
| Shareholder | % | Value (M) |
|---|---|---|
| Proven Venture Capital Plt | 16.32% | 5.6 |
| Pixelvest Sdn Bhd | 7.54% | 2.59 |
| Leong Yien Hung | 6.15% | 2.11 |
| Bintai Trading Sdn Bhd | 5.19% | 1.78 |
| Dynamic Prestige Consultancy Sdn Bhd | 4.43% | 1.52 |
| Magnalogic Sdn Bhd | 4.35% | 1.49 |
| Lim Wai Yee | 3.38% | 1.16 |
| Rinani Group Berhad | 2.07% | 0.71 |
| Munirah binti Haji Abdul Hamid | 1.77% | 0.61 |
| Keh Chuan Choon | 1.62% | 0.56 |
| Ong Tzu Chuen | 1.57% | 0.54 |
| Mohd Rafael bin Mohd Shamsudin | 1.56% | 0.54 |
| Yeo Tsu Sin | 1.47% | 0.5 |